logo

Xeris Biopharma Holdings Inc: Navigating Market Fluctuations with a 299.65M Market Cap

Xeris Biopharma Holdings Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $3.26 on 02/15/24, while the lowest price for the same duration was marked at $1.46 on 11/15/23.

52-week price history of XERS Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Xeris Biopharma Holdings Inc’s current trading price is -38.00% away from its 52-week high, while its distance from the 52-week low is 38.43%. The stock’s price range during this period has spanned from $1.46 to $3.26. In the Healthcare sector, the Xeris Biopharma Holdings Inc’s shares surpassed a trading volume of approximately 1.25 million for the day, which was noticeably lower compared to the average daily volume of 9.1.8 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Xeris Biopharma Holdings Inc (XERS) has experienced a quarterly decline of -37.04% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 299.65M and boasts a workforce of 377 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.3335, with a change in price of +0.0050. Similarly, Xeris Biopharma Holdings Inc recorded 1,998,184 in trading volume during the last 100 days, posting a change of +0.25%.

XERS Stock Stochastic Average

Today, Xeris Biopharma Holdings Inc’s raw stochastic average for the past 50 days stands at 24.07%, indicating a decline from the raw stochastic average of the last 20 days, which was 90.28%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 78.04% and 61.43% respectively.

XERS Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price loss of -14.00% this year. Over the last six months, there has been a weaker performance of 24.76%. The price of XERS fallen by 12.28% during the last 30 days period. For the last 5-days stocks have improved 9.25%.

Most Popular